BioSpace News Archive

New York Blood Center Enterprises and Talaris Therapeutics, Inc. announced NYBCe’s acquisition of commercial-scale cell and gene therapy development and manufacturing facilities, as well as certain technologies and equipment from Talaris in Houston, Texas and Louisville, Kentucky.

Coherus BioSciences, Inc., announced that sales of CIMERLI® to retinal specialists have exceeded 100,000 doses since commercial launch on October 3, 2022.

Arcturus Therapeutics Holdings Inc. announced today that ARCALIS, Arcturus’ manufacturing joint venture in Japan to support the production of mRNA vaccines and therapeutics, has been selected by the Japanese Ministry of Economy, Trade and Industry to receive additional financial support to construct a DNA template manufacturing facility along with new state-of-the-art equipment.

Shineco, Inc. announced that it plans to increase its research and development of new high-tech applications of silk protein in the health and medical field in conjunction with its existing silkworm business segment.

BiomX Inc. announced the completion of patient dosing in Part 2 of the Phase 1b/2a trial evaluating the Company’s novel phage cocktail, BX004, for the treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.

Karuna Therapeutics, Inc. announced it will be presenting new secondary efficacy, safety and tolerability, and pooled cognition data from its EMERGENT clinical program evaluating KarXT in schizophrenia.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that the European Patent Office issued European Patent No. 3242676 to the Company on October 4, 2023.

Freeline Therapeutics Holdings plc reported positive initial safety, tolerability and enzyme activity data from the ongoing Phase 1/2 GALILEO-1 trial evaluating FLT201, its adeno-associated virus gene therapy candidate, in Gaucher disease.

Renexxion LLC announced that the company will present at the Oppenheimer Healthcare Private Company Showcase on Wednesday, October 11th, 2023.

Bausch + Lomb Corporation today announced one podium presentation and four poster presentations during the American Academy of Optometry (AAOpt) annual meeting, which will take place in New Orleans Oct. 11-14, 2023.